Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
McKesson Corporation, a leading name in the pharmaceutical preparation manufacturing industry, is headquartered in the United States. Founded in 1833, McKesson has established itself as a pivotal player in healthcare, providing a wide range of services including pharmaceutical distribution, healthcare management, and technology solutions.
With major operations across North America, McKesson is renowned for its commitment to improving patient care through innovative products and services. The company’s core offerings include prescription medications, medical supplies, and health information technology, all designed to enhance efficiency and accessibility in healthcare delivery.
Recognised for its market leadership, McKesson consistently ranks among the top companies in the Fortune 500, reflecting its significant impact on the healthcare landscape. Its dedication to quality and service excellence sets McKesson apart in a competitive industry.
+24 vs industry average
Mckesson’s score of 66 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
McKesson, a US-headquartered company in Pharmaceutical Preparation Manufacturing, has detailed its global carbon emissions and climate commitments.
In 2025, McKesson reported total Scope 1, 2, and 3 emissions of approximately 36.27 billion kg CO2e. This includes Scope 1 emissions of 72.22 million kg CO2e, market-based Scope 2 emissions of 119.94 million kg CO2e, and Scope 3 emissions of approximately 36.08 billion kg CO2e. The largest contributors to Scope 3 were purchased goods and services, accounting for approximately 35.58 billion kg CO2e, and upstream transportation and distribution at 285.63 million kg CO2e.
Looking back, McKesson's emissions in previous years were:
McKesson has set Science-Based Targets initiative (SBTi) approved reduction targets. The company is committed to reducing absolute Scope 1 and 2 greenhouse gas emissions by 50.4% by fiscal year 2032, using a fiscal year 2020 base year. Additionally, McKesson aims for 70% of its suppliers, by spend covering purchased goods and services, to have science-based targets by fiscal year 2027. These targets are considered consistent with reductions required to keep global warming to 1.5°C.
2032
50.4% reduction in Scope 2
2032
50.4% reduction in Scope 2
McKesson commits to reduce absolute scope 1 and 2 GHG emissions 50.4% by FY2032 from a FY2020 base year. McKesson commits that 70% of its su…
2032
50.4% reduction in Scope 1
McKesson commits to reduce absolute scope 1 and 2 GHG emissions 50.4% by FY2032 from a FY2020 base year. McKesson commits that 70% of its su…
See all 4 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Mckesson’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more